News | April 09, 2007

DocuSys Inc. Releases New Version of Drug Monitoring Device for the OR

April 10, 2007 - DocuSys Inc., a provider of Anesthesia Information Systems (AIS) and Digital Drug Management Systems, announced the release of its second generation DocuJect, a point-of-care safety device for monitoring drug deliveries in the OR environment.

The announcement comes on the heels of the release of a widely publicized new study by the U.S. Pharmacopeia revealing that 5 percent of perioperative errors result in harm and that drug dose (particularly in pediatric patients) and communication errors were common causes of these errors. The study found that surgery patients are three times more likely to experience a harmful medication error than patients anywhere else in the health care system, prompting the following comment from one of the study's authors, Peter Pronovost, M.D., Ph.D., who is familiar with the DocuJect product. "Among other strategies, technologies like DocuJect that automate drug delivery hold promise to reduce these harmful events."

DocuJect combines digital imaging and bar code scanning technologies to enable instant interaction with patient and drug databases to provide alerts to the clinician before an impending adverse drug reaction or medication error can occur. The device also automates documentation of drug delivery in real- time. Installation of DocuJect II in DocuSys hospitals will begin in April.

Related Content

Varian announced it has received FDA 510(k) clearance for its Ethos therapy, an Adaptive Intelligence solution. Ethos therapy is an artificial intelligence (AI)-driven holistic solution that provides an opportunity to transform cancer care.
News | Image Guided Radiation Therapy (IGRT) | February 11, 2020
February 11, 2020 — Varian announced it has received FDA 510(k) c
Philips launches Azurion with FlexArm to set new standard for the future of image-guided procedures

Philips launches Azurion with FlexArm to set new standard for the future of image-guided procedures.

News | Radiology Imaging | December 12, 2019
December 12, 2019 — Philips and the Regional Medical Center
Patient Treatments With ViewRay's MRIdian Linac Begin in New England
News | Image Guided Radiation Therapy (IGRT) | October 08, 2019
ViewRay Inc. announced today that patient treatments are scheduled to begin in Boston with ViewRay's MRIdian Linac...
Varian Unveils Ethos Solution for Adaptive Radiation Therapy
News | Image Guided Radiation Therapy (IGRT) | September 16, 2019
At the 2019 American Society for Radiation Oncology (ASTRO) annual meeting, being held Sept. 15-18 in Chicago, Varian...
ASTRO 2019 to Feature Clinical Experience and Patient Outcomes With Viewray MRIdian
News | Image Guided Radiation Therapy (IGRT) | September 11, 2019
ViewRay Inc. announced that the company's MRIdian and MRIdian Linac magnetic resonance imaging (MRI)-guided radiation...
Beamscan MR 3D water phantom – the first 3-D water phantom for magnetic resonance (MR)-guided radiotherapy
News | Radiation Therapy | August 27, 2019
Radiation dosimetry company announced plans to exhibit its full range of radiation therapy dosimetry solutions for...
First Cancer Patient Treated With Accuray Radixact System With Synchrony Motion Tracking
News | Image Guided Radiation Therapy (IGRT) | August 21, 2019
Physicians at the Froedtert & the Medical College of Wisconsin (MCW) Clinical Cancer Center in Milwaukee have...
MD Anderson to Expand Proton Therapy Center

The MD Anderson Proton Therapy Center expansion is expected to be completed in 2023. Rendering courtesy of Stantec.

News | Proton Therapy | August 08, 2019
The University of Texas MD Anderson Cancer Center unveiled plans to expand its Proton Therapy Center during a...